Attenuation of the Neural Response to Sad Faces in Major Depressionby Antidepressant Treatment: A Prospective, Event-Related Functional Magnetic Resonance ImagingStudy

Department of Psychiatry, University of Cambridge, Cambridge, England, United Kingdom
Archives of General Psychiatry (Impact Factor: 14.48). 10/2004; 61(9):877-89. DOI: 10.1001/archpsyc.61.9.877
Source: PubMed


Depression is associated with interpersonal difficulties related to abnormalities in affective facial processing.
To map brain systems activated by sad facial affect processing in patients with depression and to identify brain functional correlates of antidepressant treatment and symptomatic response.
Two groups underwent scanning twice using functional magnetic resonance imaging (fMRI) during an 8-week period. The event-related fMRI paradigm entailed incidental affect recognition of facial stimuli morphed to express discriminable intensities of sadness.
Participants were recruited by advertisement from the local population; depressed subjects were treated as outpatients.
We matched 19 medication-free, acutely symptomatic patients satisfying DSM-IV criteria for unipolar major depressive disorder by age, sex, and IQ with 19 healthy volunteers. Intervention After the baseline assessment, patients received fluoxetine hydrochloride, 20 mg/d, for 8 weeks.
Average activation (capacity) and differential response to variable affective intensity (dynamic range) were estimated in each fMRI time series. We used analysis of variance to identify brain regions that demonstrated a main effect of group (depressed vs healthy subjects) and a group x time interaction (attributable to antidepressant treatment). Change in brain activation associated with reduction of depressive symptoms in the patient group was identified by means of regression analysis. Permutation tests were used for inference.
Over time, depressed subjects showed reduced capacity for activation in the left amygdala, ventral striatum, and frontoparietal cortex and a negatively correlated increase of dynamic range in the prefrontal cortex. Symptomatic improvement was associated with reduction of dynamic range in the pregenual cingulate cortex, ventral striatum, and cerebellum.
Antidepressant treatment reduces left limbic, subcortical, and neocortical capacity for activation in depressed subjects and increases the dynamic range of the left prefrontal cortex. Changes in anterior cingulate function associated with symptomatic improvement indicate that fMRI may be a useful surrogate marker of antidepressant treatment response.

Download full-text


Available from: John Suckling, Mar 06, 2014
  • Source
    • "In accordance with resting state findings , results under task state also have been inconsistent . Inconsistencies across different studies may be due to differences in study populations ( Gotlib et al . , 2004 ) and methodology . For instance , drug treatments for depression or anxiety may significantly alter emotional processing ( Fu et al . , 2004 ) . In addition , prior studies used different experimental paradigms , which may assess different time courses of emotional processing ( Tamietto and de Gelder , 2010 ; Shi et al . , 2013 ) . Grimm et al . ( 2011 ) found that during performance of a self - related task , MDD patients showed decreased deactivation in anterior medial cor"
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous studies have focused on resting-state default mode network (DMN) alterations in the development and maintenance of depression; however, only a few studies have addressed DMN changes during task-related processing and their results are inconsistent. Therefore, we explored DMN patterns in young adult patients with first-episode, treatment-naïve major depressive disorder (MDD) performing an implicit emotional processing task. Patients with MDD (N = 29) and healthy controls (N = 33) were subjected to functional magnetic resonance imaging (fMRI) at rest and while performing a gender judgment task. Group independent component analysis (ICA) was used to identify DMN component under task state for both groups. The DMN of participants with MDD had decreased functional connectivity in bilateral prefrontal areas compared to controls. Right prefrontal gyrus connectivity for MDD patients correlated negatively with scores on maladaptive scales of the Cognitive Emotion Regulation Questionnaire (CERQ). Our findings suggest that depressed people have altered DMN patterns during implicit emotional processing, which might be related to impaired internal monitoring and emotional regulation ability.
    Frontiers in Psychology 08/2015; 6:1198. DOI:10.3389/fpsyg.2015.01198 · 2.80 Impact Factor
    • "This is also consistent with model proposed by Goldapple et al. (2004). Despite the increased interest sparked by neuroimaging studies that assessed brain modifications after psychotherapy (Fu et al. 2008; Schnell and Herpertz 2007; Schienle et al. 2009; Goldapple et al. 2004) and pharmacological treatment (Bremner et al. 2007; Brody et al. 1999; Chen et al. 2007; Davidson et al. 2003; Fu et al. 2004; Haldane et al. 2008; Jogia et al. 2008; Kalin et al. 1997; Kennedy et al. 2001; Mayberg et al. 2000; Pizzagalli et al. 2001; Saxena et al. 2003; Vlassenko et al. 2004; Goldapple et al. 2004), it is still unclear whether the same neural mechanisms underlie both PsyTh and DrugTh. Indeed, because of the great heterogeneity of these studies, especially regarding the type of psychiatric disorder and experimental paradigm, we are still far from reaching an unambiguous conclusion. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The idea that modifications of affect, behavior and cognition produced by psychotherapy are mediated by biological underpinnings predates the advent of the modern neurosciences. Recently, several studies demonstrated that psychotherapy outcomes are linked to modifications in specific brain regions. This opened the debate over the similarities and dissimilarities between psychotherapy and pharmacotherapy. In this study, we used activation likelihood estimation meta-analysis to investigate the effects of psychotherapy (PsyTh) and pharmacotherapy (DrugTh) on brain functioning in Major Depression (MD). Our results demonstrate that the two therapies modify different neural circuits. Specifically, PsyTh induces selective modifications in the left inferior and superior frontal gyri, middle temporal gyrus, lingual gyrus and middle cingulate cortex, as well as in the right middle frontal gyrus and precentral gyrus. Otherwise, DrugTh selectively affected brain activation in the right insula in MD patients. These results are in line with previous evidence of the synergy between psychotherapy and pharmacotherapy but they also demonstrate that the two therapies have different neural underpinnings.
    Brain Imaging and Behavior 07/2015; DOI:10.1007/s11682-015-9429-x · 4.60 Impact Factor
  • Source
    • "Aside from its role as a model for schizophrenia, ketamine has gained attention as a treatment for treatment-resistant depression. Although research in this scientific field has focused particularly on neuroplastic properties of ketamine (Li et al., 2010, 2011), the fact that depression significantly alters thalamic functioning as revealed by fMRI studies in depressed patients (Fu et al., 2004; Dichter et al., 2009; for review, see Hoflich et al., 2012) might point toward the relevance of the results gained in this study also in the context of depression. A limitation of this study is the lack of direct comparison of results in patients with schizophrenia and changes seen in "
    [Show abstract] [Hide abstract]
    ABSTRACT: Schizophrenia has been associated with disturbances of thalamic functioning. In the light of recent evidence suggesting a significant impact of the glutamatergic system on key symptoms of schizophrenia, we assessed whether the modulation of the glutamatergic system via blockage of the NMDA-receptor might lead to changes of thalamic functional connectivity. Based on the "ketamine-model" of psychosis we investigated changes in cortico-thalamic functional connectivity by intravenous ketamine challenge during a 55 minutes resting-state scan. 30 healthy volunteers were measured with pharmacological functional magnetic resonance imaging (fMRI) using a double-blind, randomized, placebo-controlled, crossover design. Functional connectivity analysis revealed significant ketamine-specific changes within the "thalamus hub network", more precisely an increase of cortico-thalamic connectivity of the somatosensory and temporal cortex. Our results indicate that changes of thalamic functioning as described for schizophrenia can be partly mimicked by NMDA-receptor blockage. This adds substantial knowledge about the neurobiological mechanisms underlying the profound changes of perception and behaviour during the application of NMDA-receptor antagonists. © The Author 2014. Published by Oxford University Press on behalf of CINP.
    The International Journal of Neuropsychopharmacology 04/2015; DOI:10.1093/ijnp/pyv040 · 4.01 Impact Factor
Show more

Similar Publications